73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainRadiotherapy after breast-conserving surgery in conjunction with chemotherapy or tamoxifen to treat early

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainRadiotherapy after breast-conserving surgery in conjunction with chemotherapy or tamoxifen to treat early
Clinical trial reveals new subtypes of advanced pancreatic cancer

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne
MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li
Multi-center study sheds light on understudied breast cancer type

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre
Advanced imaging may help in clinical treatment of prostate cancer

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare
Scientists identify promising therapeutic target for incurable brain cancer

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co
Are inflammatory bowel disease patients more at risk of colorectal cancer

Are inflammatory bowel disease patients more at risk of colorectal cancer

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of

Are inflammatory bowel disease patients more at risk of colorectal cancer

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of
Researchers identify potential formula for blood cancer vaccine

Researchers identify potential formula for blood cancer vaccine

byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at

Researchers identify potential formula for blood cancer vaccine

byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at
Scientists find powerhouses that fight tumours from within

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor
After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v
Scientists develop new ultrasound technique for earlier detection and diagnosis of breast cancer

Scientists develop new ultrasound technique for earlier detection and diagnosis of breast cancer

byNational Physical LaboratoryCredit: Unsplash/CC0 Public DomainScientists at the UK's National Physical Laboratory (NPL) have demonstrated the first in-person measurements of breast tissue

Scientists develop new ultrasound technique for earlier detection and diagnosis of breast cancer

byNational Physical LaboratoryCredit: Unsplash/CC0 Public DomainScientists at the UK's National Physical Laboratory (NPL) have demonstrated the first in-person measurements of breast tissue